{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:41:25Z","timestamp":1787992885270,"version":"build-2784847793"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Homeopathy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Context\u2003The use of homeopathy in oncological supportive care seems to be progressing. The first French prevalence study, performed in 2005 in Strasbourg, showed that only 17% of the subjects were using it. What is the situation 12 years later?<\/jats:p><jats:p>\n          Materials and Methods\u2003This is a descriptive study, using a questionnaire identical to that used in 2005, on 633 patients undergoing treatment in three anti-cancer centers in Strasbourg. The results of the \u201chomeopathy\u201d sub-group were extracted and studied.<\/jats:p><jats:p>\n          Results\u2003Of the 535 patients included, 164 used homeopathy: that is 30.7%. The main purpose of its use was to reduce the side effects of cancer treatments (75%). Among the users, 82.6% were \u201csomewhat\u201d or \u201cvery\u201d satisfied, against \u201cquite\u201d satisfied for 15.5%, and \u201cnot at all\u201d satisfied for 1.9%. The homeopathic treatment was prescribed by a doctor in 75.6% of the cases; the general practitioner was kept informed in 87% of the cases and the oncologist in 82%. Fatigue, pain, nausea, anxiety, sadness and diarrhea were improved in 80% of the cases. However, alopecia, weight disorders and loss of libido were the least improved symptoms. The use of homeopathy was significantly associated with the female sex.<\/jats:p><jats:p>\n          Conclusion\u2003With a prevalence of 30.7%, homeopathy is the most used complementary medicine in integrative oncology in Strasbourg. Over 12 years, we have witnessed an increase of 83% in its use in the same city. Almost all respondents declare themselves satisfied and tell their doctors more readily than in 2005.<\/jats:p>","DOI":"10.1055\/s-0040-1721065","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T23:45:42Z","timestamp":1614901542000},"source":"Crossref","is-referenced-by-count":6,"title":["Use of Homeopathy in Integrative Oncology in Strasbourg, France: Multi-center Cross-Sectional Descriptive Study of Patients Undergoing Cancer Treatment"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-1369","authenticated-orcid":false,"given":"J-L","family":"Bagot","sequence":"additional","affiliation":[{"name":"Saint-Vincent Hospital Group, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Legrand","sequence":"additional","affiliation":[{"name":"Cabinet of General Medicine, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Theunissen","sequence":"additional","affiliation":[{"name":"H\u00f4pital Delta, Chirec, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-015-0467-8","article-title":"Is there a role for homeopathy in cancer care? Questions and challenges","volume":"17","author":"M Frenkel","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"ref2","first-page":"483","article-title":"[Complementary and alternative medicines taken by cancer patients]","volume":"94","author":"L Simon","year":"2007","journal-title":"Bull Cancer"},{"key":"ref3","first-page":"1017","article-title":"Utilisation de m\u00e9decine compl\u00e9mentaire chez les patients atteints de cancer dans un service de canc\u00e9rologie fran\u00e7ais","volume":"94","author":"S Tr\u00e4ger-Maury","year":"2007","journal-title":"Bull Cancer"},{"key":"ref4","first-page":"95","volume-title":"Utilisation des m\u00e9decines alternatives et compl\u00e9mentaires par les patients en canc\u00e9rologie: r\u00e9sultats de l'\u00e9tude Mac-Aerio Eurocancer 2010","author":"M Rodrigues","year":"2010"},{"key":"ref6","first-page":"10","volume-title":"Etude de la pr\u00e9valence de l'utilisation des m\u00e9decines compl\u00e9mentaires par les patients atteints de cancer","author":"A Legrand","year":"2018"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0038-1670689","article-title":"Reasons for use of and experiences with homeopathic treatment as an adjunct to usual cancer care: results of a small qualitative study","volume":"108","author":"C Yde","year":"2019","journal-title":"Homeopathy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00520-014-2517-4","article-title":"Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe","volume":"23","author":"E Rossi","year":"2015","journal-title":"Support Care Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1636839","article-title":"Integration of homeopathy and complementary medicine in the Tuscan public health system and the experience of the homeopathic clinic of the Lucca Hospital","volume":"107","author":"E Rossi","year":"2018","journal-title":"Homeopathy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00404-017-4420-y","article-title":"Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey","volume":"296","author":"E Klein","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1534735415596423","article-title":"Complementary and alternative medicine in palliative care: a comparison of data from surveys among patients and professionals","volume":"15","author":"R Muecke","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.revhom.2017.10.015","article-title":"Therapeutic recommendations of the International Homeopathic Society of Supportive Care in Oncology \u201c(IHSSCO)","volume":"8","author":"J L Bagot","year":"2017","journal-title":"La Revue d'Hom\u00e9opathie"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ctim.2015.03.004","article-title":"Influence of adjunctive classical homeopathy on global health status and subjective wellbeing in cancer patients\u2014a pragmatic randomized controlled trial","volume":"23","author":"M Frass","year":"2015","journal-title":"Complement Ther Med"},{"key":"ref15","first-page":"18","article-title":"Integrated oncology in an integrated medicine hospital in Pitigliano (Grosseto, Italy)","volume":"4","author":"R Ferreri","year":"2019","journal-title":"OBM Integr Complementary Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.revhom.2016.07.022","article-title":"Homeopathy: a complementary and interstitial medicine in severe pathologies","volume":"7","author":"J L Bagot","year":"2016","journal-title":"La Revue d'Hom\u00e9opathie"},{"key":"ref17","first-page":"CD004845","article-title":"Homeopathic medicines for adverse effects of cancer treatments","author":"S Kassab","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1054\/homp.1999.0378","article-title":"Do homeopathic medicines provoke adverse effects? A systematic review","volume":"89","author":"F Dantas","year":"2000","journal-title":"Br Homeopath J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/medicines4040093","article-title":"Patient safety in complementary medicine through the application of clinical risk management in the public health system","volume":"4","author":"E G Rossi","year":"2017","journal-title":"Medicines (Basel)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoncol.2019.0349","article-title":"Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States","volume":"5","author":"N N Sanford","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Homeopathy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1721065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T23:46:05Z","timestamp":1614901565000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1721065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1055\/s-0040-1721065","relation":{},"ISSN":["1475-4916","1476-4245"],"issn-type":[{"value":"1475-4916","type":"print"},{"value":"1476-4245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}